age at least 18 Years
Item
age at least 18 Years
boolean
C0001779 (UMLS CUI 2011AA)
397669002 (SNOMED CT 2011_0131)
Histologically or cytologically confirmed, unresectable urothelial carcinoma of the bladder or the upper urinary tract
Item
Histologically or cytologically confirmed, unresectable urothelial carcinoma of the bladder or the upper urinary tract
boolean
C0205462 (UMLS CUI 2011AA)
67151002 (SNOMED CT 2011_0131)
C0205471 (UMLS CUI 2011AA)
40413002 (SNOMED CT 2011_0131)
C0750484 (UMLS CUI 2011AA)
C1519810 (UMLS CUI 2011AA)
C0279680 (UMLS CUI 2011AA)
255109008 (SNOMED CT 2011_0131)
10046714 (MedDRA 14.1)
C0011900 (UMLS CUI 2011AA)
439401001 (SNOMED CT 2011_0131)
MTHU008876 (LOINC Version 232)
CL363966 (UMLS CUI 2011AA)
C0729865 (UMLS CUI 2011AA)
Wild-type HRAS
Item
Wild-type HRAS
boolean
C0678926 (UMLS CUI 2011AA)
C0079471 (UMLS CUI 2011AA)
Male and female subjects > 18 years of age
Item
Male and female subjects > 18 years of age
boolean
C0024554 (UMLS CUI 2011AA)
248153007 (SNOMED CT 2011_0131)
M (HL7 V3 2006_05)
C0015780 (UMLS CUI 2011AA)
248152002 (SNOMED CT 2011_0131)
F (HL7 V3 2006_05)
General condition ECOG 0-1
Item
General condition ECOG 0-1
boolean
C0947124 (UMLS CUI 2011AA)
MTHU001443 (LOINC Version 232)
C1828078 (UMLS CUI 2011AA)
425389002 (SNOMED CT 2011_0131)
C1827388 (UMLS CUI 2011AA)
422512005 (SNOMED CT 2011_0131)
Life expectancy at least 12 weeks
Item
Life expectancy at least 12 weeks
boolean
C0023671 (UMLS CUI 2011AA)
LP75025-4 (LOINC Version 232)
C0439091 (UMLS CUI 2011AA)
276138003 (SNOMED CT 2011_0131)
GE (HL7 V3 2006_05)
C0205458 (UMLS CUI 2011AA)
82809009 (SNOMED CT 2011_0131)
C0439230 (UMLS CUI 2011AA)
258705008 (SNOMED CT 2011_0131)
WK (HL7 V3 2006_05)
Women of child-bearing potential: negative pregnancy test and use of effective contraception(oral contraceptive, coil). Men: use of adequate male contraception (condom) for up to 3 months after discontinuation of panitumumab therapy
Item
Women of child-bearing potential: negative pregnancy test and use of effective contraception(oral contraceptive, coil). Men: use of adequate male contraception (condom) for up to 3 months after discontinuation of panitumumab therapy
boolean
C0043210 (UMLS CUI 2011AA)
224526002 (SNOMED CT 2011_0131)
C1148523 (UMLS CUI 2011AA)
C0237399 (UMLS CUI 2011AA)
C0427780 (UMLS CUI 2011AA)
250425007 (SNOMED CT 2011_0131)
10036574 (MedDRA 14.1)
C0700589 (UMLS CUI 2011AA)
146680009 (SNOMED CT 2011_0131)
10010808 (MedDRA 14.1)
C0009905 (UMLS CUI 2011AA)
59261009 (SNOMED CT 2011_0131)
C0419518 (UMLS CUI 2011AA)
312082008 (SNOMED CT 2011_0131)
10009849 (MedDRA 14.1)
C0025266 (UMLS CUI 2011AA)
339947000 (SNOMED CT 2011_0131)
C0086580 (UMLS CUI 2011AA)
10065589 (MedDRA 14.1)
C0677582 (UMLS CUI 2011AA)
Locally advanced or metastatic disease (T3b,T4 and/or N+ and/or M+)
Item
Locally advanced or metastatic disease (T3b,T4 and/or N+ and/or M+)
boolean
C0677984 (UMLS CUI 2011AA)
C0027627 (UMLS CUI 2011AA)
10027478 (MedDRA 14.1)
C0475391 (UMLS CUI 2011AA)
261655000 (SNOMED CT 2011_0131)
C0475751 (UMLS CUI 2011AA)
65565005 (SNOMED CT 2011_0131)
C0441922 (UMLS CUI 2011AA)
258310009 (SNOMED CT 2011_0131)
C0441923 (UMLS CUI 2011AA)
258311008 (SNOMED CT 2011_0131)
At least one unidimensionally measurable lesion detectable in CT or MRI corresponding to the RECIST criteria
Item
At least one unidimensionally measurable lesion detectable in CT or MRI corresponding to the RECIST criteria
boolean
C0205447 (UMLS CUI 2011AA)
38112003 (SNOMED CT 2011_0131)
C0439534 (UMLS CUI 2011AA)
255506008 (SNOMED CT 2011_0131)
C1513040 (UMLS CUI 2011AA)
C0221198 (UMLS CUI 2011AA)
49755003 (SNOMED CT 2011_0131)
C1511790 (UMLS CUI 2011AA)
C0040405 (UMLS CUI 2011AA)
77477000 (SNOMED CT 2011_0131)
10010234 (MedDRA 14.1)
0002 (HL7 V3 2006_05)
C0024485 (UMLS CUI 2011AA)
113091000 (SNOMED CT 2011_0131)
10028049 (MedDRA 14.1)
C1709926 (UMLS CUI 2011AA)
Adequate haematological, hepatic, renal and metabolic function parameters:
Item
Adequate haematological, hepatic, renal and metabolic function parameters:
boolean
C0205411 (UMLS CUI 2011AA)
88323005 (SNOMED CT 2011_0131)
C0449381 (UMLS CUI 2011AA)
252116004 (SNOMED CT 2011_0131)
C0221130 (UMLS CUI 2011AA)
86084001 (SNOMED CT 2011_0131)
C0232741 (UMLS CUI 2011AA)
79036002 (SNOMED CT 2011_0131)
C0232804 (UMLS CUI 2011AA)
11953005 (SNOMED CT 2011_0131)
C0438212 (UMLS CUI 2011AA)
165105001 (SNOMED CT 2011_0131)
Leukocytes > 3000/mm³, ANC >= 1500/mm³, platelets >= 100,000/mm³, hemoglobin > 9 g/dl Creatinine clearance >= 50 ml/min and serum creatinine <= 1.5 x upper limit of normal Bilirubin <= 1.5 x upper limit of normal, GOT-GPT <= 2.5 x upper limit of normal in absence of liver metastases, or <= 5 x upper limit of normal in presence of liver metastases, AP <= 5 x upper limit of normal Magnesium >= lower limit of normal. Calcium >= lower limit of normal INR and PTT < 1.5 x the upper limit of the normal reference range
Item
Leukocytes > 3000/mm³, ANC >= 1500/mm³, platelets >= 100,000/mm³, hemoglobin > 9 g/dl Creatinine clearance >= 50 ml/min and serum creatinine <= 1.5 x upper limit of normal Bilirubin <= 1.5 x upper limit of normal, GOT-GPT <= 2.5 x upper limit of normal in absence of liver metastases, or <= 5 x upper limit of normal in presence of liver metastases, AP <= 5 x upper limit of normal Magnesium >= lower limit of normal. Calcium >= lower limit of normal INR and PTT < 1.5 x the upper limit of the normal reference range
boolean
C0023508 (UMLS CUI 2011AA)
767002 (SNOMED CT 2011_0131)
10047939 (MedDRA 14.1)
C0948762 (UMLS CUI 2011AA)
10052033 (MedDRA 14.1)
C1287267 (UMLS CUI 2011AA)
365632008 (SNOMED CT 2011_0131)
777-3 (LOINC Version 232)
C0518015 (UMLS CUI 2011AA)
10018876 (MedDRA 14.1)
C0373595 (UMLS CUI 2011AA)
167181009 (SNOMED CT 2011_0131)
10011371 (MedDRA 14.1)
C0201976 (UMLS CUI 2011AA)
113075003 (SNOMED CT 2011_0131)
10040230 (MedDRA 14.1)
C1519815 (UMLS CUI 2011AA)
C0011221 (UMLS CUI 2011AA)
79706000 (SNOMED CT 2011_0131)
1975-2 (LOINC Version 232)
C0004002 (UMLS CUI 2011AA)
26091008 (SNOMED CT 2011_0131)
MTHU004883 (LOINC Version 232)
C0001899 (UMLS CUI 2011AA)
56935002 (SNOMED CT 2011_0131)
MTHU006766 (LOINC Version 232)
C0002059 (UMLS CUI 2011AA)
57056007 (SNOMED CT 2011_0131)
MTHU005195 (LOINC Version 232)
C0373675 (UMLS CUI 2011AA)
38151008 (SNOMED CT 2011_0131)
10025436 (MedDRA 14.1)
C1518030 (UMLS CUI 2011AA)
C0201925 (UMLS CUI 2011AA)
71878006 (SNOMED CT 2011_0131)
10006948 (MedDRA 14.1)
C0525032 (UMLS CUI 2011AA)
165581004 (SNOMED CT 2011_0131)
10022400 (MedDRA 14.1)
C0030605 (UMLS CUI 2011AA)
42525009 (SNOMED CT 2011_0131)
10000630 (MedDRA 14.1)
HRAS mutation
Item
HRAS mutation
boolean
C0079471 (UMLS CUI 2011AA)
C0026882 (UMLS CUI 2011AA)
55446002 (SNOMED CT 2011_0131)
Absence of any of the above-listed inclusion criteria
Item
Absence of any of the above-listed inclusion criteria
boolean
C0332197 (UMLS CUI 2011AA)
2667000 (SNOMED CT 2011_0131)
CL407060 (UMLS CUI 2011AA)
CL425202 (UMLS CUI 2011AA)
CL384738 (UMLS CUI 2011AA)
Dialysis-dependence following nephrectomy
Item
Dialysis-dependence following nephrectomy
boolean
C0011946 (UMLS CUI 2011AA)
108241001 (SNOMED CT 2011_0131)
10061105 (MedDRA 14.1)
CL414916 (UMLS CUI 2011AA)
C0332282 (UMLS CUI 2011AA)
255260001 (SNOMED CT 2011_0131)
C0027695 (UMLS CUI 2011AA)
108022006 (SNOMED CT 2011_0131)
10029116 (MedDRA 14.1)
Patients with cerebral tumours and/or cerebral metastases
Item
Patients with cerebral tumours and/or cerebral metastases
boolean
C1263885 (UMLS CUI 2011AA)
126953009 (SNOMED CT 2011_0131)
C0555278 (UMLS CUI 2011AA)
94248000 (SNOMED CT 2011_0131)
Clinically significant cardiovascular disease in (incl. myocardial infarction, unstable angina, symptomatic congestive heart failure, serious uncontrolled cardiac arrhythmia) <= 1 year before enrolment.
Item
Clinically significant cardiovascular disease in (incl. myocardial infarction, unstable angina, symptomatic congestive heart failure, serious uncontrolled cardiac arrhythmia) <= 1 year before enrolment.
boolean
C0007222 (UMLS CUI 2011AA)
105980002 (SNOMED CT 2011_0131)
10007649 (MedDRA 14.1)
429.2 (ICD-9-CM Version 2011)
C0027051 (UMLS CUI 2011AA)
22298006 (SNOMED CT 2011_0131)
10028596 (MedDRA 14.1)
MTHU035551 (LOINC Version 232)
I21-I22 (ICD-10-CM Version 2010)
410 (ICD-9-CM Version 2011)
E10152 (CTCAE 1105E)
C0002965 (UMLS CUI 2011AA)
4557003 (SNOMED CT 2011_0131)
10002388 (MedDRA 14.1)
I20.0 (ICD-10-CM Version 2010)
411.1 (ICD-9-CM Version 2011)
C0018802 (UMLS CUI 2011AA)
42343007 (SNOMED CT 2011_0131)
10007559 (MedDRA 14.1)
MTHU020787 (LOINC Version 232)
I50.9 (ICD-10-CM Version 2010)
428.0 (ICD-9-CM Version 2011)
C0205318 (UMLS CUI 2011AA)
19032002 (SNOMED CT 2011_0131)
C0003811 (UMLS CUI 2011AA)
44808001 (SNOMED CT 2011_0131)
10003119 (MedDRA 14.1)
427.9 (ICD-9-CM Version 2011)
Patients with uncontrolled hypertension. Systolic blood pressure > 150 mmHg or diastolic blood pressure > 90 mmHg despite optimal medical treatment
Item
Patients with uncontrolled hypertension. Systolic blood pressure > 150 mmHg or diastolic blood pressure > 90 mmHg despite optimal medical treatment
boolean
C1868885 (UMLS CUI 2011AA)
10066860 (MedDRA 14.1)
C1306620 (UMLS CUI 2011AA)
10005756 (MedDRA 14.1)
C0428883 (UMLS CUI 2011AA)
271650006 (SNOMED CT 2011_0131)
C0162643 (UMLS CUI 2011AA)
10066901 (MedDRA 14.1)
History of interstitial lung disease, e.g. pneumonitis or pulmonary fibrosis or evidence of interstitial lung disease on baseline chest CT scan.
Item
History of interstitial lung disease, e.g. pneumonitis or pulmonary fibrosis or evidence of interstitial lung disease on baseline chest CT scan.
boolean
CL421546 (UMLS CUI 2011AA)
392521001 (SNOMED CT 2011_0131)
C0206062 (UMLS CUI 2011AA)
233703007 (SNOMED CT 2011_0131)
10022611 (MedDRA 14.1)
J84.9 (ICD-10-CM Version 2010)
C1442488 (UMLS CUI 2011AA)
C0202823 (UMLS CUI 2011AA)
169069000 (SNOMED CT 2011_0131)
10053875 (MedDRA 14.1)
87.41 (ICD-9-CM Version 2011)
C0032285 (UMLS CUI 2011AA)
233604007 (SNOMED CT 2011_0131)
10035664 (MedDRA 14.1)
MTHU020831 (LOINC Version 232)
J18.9 (ICD-10-CM Version 2010)
E13502 (CTCAE 1105E)
C0034069 (UMLS CUI 2011AA)
51615001 (SNOMED CT 2011_0131)
10037383 (MedDRA 14.1)
J84.1 (ICD-10-CM Version 2010)
E13527 (CTCAE 1105E)
Patients with thrombotic or embolic events, such as stroke or pulmonary embolism
Item
Patients with thrombotic or embolic events, such as stroke or pulmonary embolism
boolean
C0857496 (UMLS CUI 2011AA)
10043565 (MedDRA 14.1)
C0038454 (UMLS CUI 2011AA)
230690007 (SNOMED CT 2011_0131)
10042244 (MedDRA 14.1)
I63.9 (ICD-10-CM Version 2010)
E12826 (CTCAE 1105E)
C0034065 (UMLS CUI 2011AA)
59282003 (SNOMED CT 2011_0131)
10037377 (MedDRA 14.1)
I26 (ICD-10-CM Version 2010)
415.1 (ICD-9-CM Version 2011)
Patients with recent or known history of haemorrhagic diathesis
Item
Patients with recent or known history of haemorrhagic diathesis
boolean
C0332185 (UMLS CUI 2011AA)
6493001 (SNOMED CT 2011_0131)
CL421546 (UMLS CUI 2011AA)
392521001 (SNOMED CT 2011_0131)
C0019087 (UMLS CUI 2011AA)
10019009 (MedDRA 14.1)
D69.9 (ICD-10-CM Version 2010)
287.9 (ICD-9-CM Version 2011)
Known significant neurological or psychiatric disorders, including dementia and epileptic seizures
Item
Known significant neurological or psychiatric disorders, including dementia and epileptic seizures
boolean
C0027765 (UMLS CUI 2011AA)
118940003 (SNOMED CT 2011_0131)
10029202 (MedDRA 14.1)
G98.8 (ICD-10-CM Version 2010)
349.9 (ICD-9-CM Version 2011)
C0004936 (UMLS CUI 2011AA)
74732009 (SNOMED CT 2011_0131)
10037174 (MedDRA 14.1)
F99 (ICD-10-CM Version 2010)
290-319.99 (ICD-9-CM Version 2011)
C0497327 (UMLS CUI 2011AA)
52448006 (SNOMED CT 2011_0131)
10012267 (MedDRA 14.1)
F03 (ICD-10-CM Version 2010)
290 (ICD-9-CM Version 2011)
C0014544 (UMLS CUI 2011AA)
84757009, 313307000 (SNOMED CT 2011_0131)
10015037 (MedDRA 14.1)
MTHU020586 (LOINC Version 232)
G40.9 (ICD-10-CM Version 2010)
345.9 (ICD-9-CM Version 2011)
Serious inflammatory eye conditions, hearing impairment
Item
Serious inflammatory eye conditions, hearing impairment
boolean
C0333348 (UMLS CUI 2011AA)
C0015392 (UMLS CUI 2011AA)
81745001 (SNOMED CT 2011_0131)
MTHU000064 (LOINC Version 232)
C0348080 (UMLS CUI 2011AA)
260905004 (SNOMED CT 2011_0131)
COND (HL7 V3 2006_05)
C1384666 (UMLS CUI 2011AA)
E10276 (CTCAE 1105E)
Pulmonary (pO2 < 60 mmHg), haemopoietic (e.g. serious bone marrow aplasia), hepatic or renal disorders
Item
Pulmonary (pO2 < 60 mmHg), haemopoietic (e.g. serious bone marrow aplasia), hepatic or renal disorders
boolean
C0024115 (UMLS CUI 2011AA)
19829001 (SNOMED CT 2011_0131)
10025082 (MedDRA 14.1)
J98.4 (ICD-10-CM Version 2010)
C0202155 (UMLS CUI 2011AA)
25579001 (SNOMED CT 2011_0131)
10035766 (MedDRA 14.1)
C0018939 (UMLS CUI 2011AA)
191124002 (SNOMED CT 2011_0131)
10061590 (MedDRA 14.1)
D75.9 (ICD-10-CM Version 2010)
289.9 (ICD-9-CM Version 2011)
C0005953 (UMLS CUI 2011AA)
14016003 (SNOMED CT 2011_0131)
MTHU016536 (LOINC Version 232)
C0243065 (UMLS CUI 2011AA)
45486003 (SNOMED CT 2011_0131)
10002961 (MedDRA 14.1)
C1869009 (UMLS CUI 2011AA)
20000005 (MedDRA 14.1)
C0022658 (UMLS CUI 2011AA)
90708001 (SNOMED CT 2011_0131)
10029151 (MedDRA 14.1)
N18.9 (ICD-10-CM Version 2010)
Patients with poorly controlled diabetes mellitus
Item
Diabetes mellitus poor control
boolean
C0860161 (UMLS CUI 2011AA)
10012619 (MedDRA 14.1)
Serious bacterial or fungal infections (>grade 2 NCI CTC Version 3)
Item
Serious bacterial or fungal infections (>grade 2 NCI CTC Version 3)
boolean
C0004623 (UMLS CUI 2011AA)
87628006 (SNOMED CT 2011_0131)
10060945 (MedDRA 14.1)
A49.9 (ICD-10-CM Version 2010)
C0026946 (UMLS CUI 2011AA)
3218000 (SNOMED CT 2011_0131)
10017533 (MedDRA 14.1)
B35-B49 (ICD-10-CM Version 2010)
110-118.99 (ICD-9-CM Version 2011)
C1560948 (UMLS CUI 2011AA)
MTHU114619 (CTCAE 1105E)
C1560949 (UMLS CUI 2011AA)
MTHU115603 (CTCAE 1105E)
C1560950 (UMLS CUI 2011AA)
MTHU116429 (CTCAE 1105E)
Chronic hepatitis B or C. HIV infection
Item
Chronic hepatitis B or C. HIV infection
boolean
C0524909 (UMLS CUI 2011AA)
61977001 (SNOMED CT 2011_0131)
10008910 (MedDRA 14.1)
B18.1 (ICD-10-CM Version 2010)
C0524910 (UMLS CUI 2011AA)
128302006 (SNOMED CT 2011_0131)
10008912 (MedDRA 14.1)
B18.2 (ICD-10-CM Version 2010)
C0019693 (UMLS CUI 2011AA)
86406008 (SNOMED CT 2011_0131)
10020161 (MedDRA 14.1)
MTHU020829 (LOINC Version 232)
B20 (ICD-10-CM Version 2010)
042 (ICD-9-CM Version 2011)
Autoimmune disease
Item
Autoimmune Disease
boolean
C0004364 (UMLS CUI 2011AA)
85828009 (SNOMED CT 2011_0131)
10061664 (MedDRA 14.1)
M30-M36 (ICD-10-CM Version 2010)
E11258 (CTCAE 1105E)
Allergic reaction to one of the medications to be used
Item
Allergic reaction to one of the medications to be used
boolean
C0020517 (UMLS CUI 2011AA)
418634005 (SNOMED CT 2011_0131)
T78.40 (ICD-10-CM Version 2010)
C0304229 (UMLS CUI 2011AA)
902003 (SNOMED CT 2011_0131)
Status post organ transplantation
Item
Status post organ transplantation
boolean
C0231290 (UMLS CUI 2011AA)
237679004 (SNOMED CT 2011_0131)
C0029216 (UMLS CUI 2011AA)
10061890 (MedDRA 14.1)
MTHU000173 (LOINC Version 232)
Status post autologous bone marrow transplantation or stem cell transplantation in the 4 months prior to study commencement
Item
Status post autologous bone marrow transplantation or stem cell transplantation in the 4 months prior to study commencement
boolean
C0231290 (UMLS CUI 2011AA)
237679004 (SNOMED CT 2011_0131)
C0194037 (UMLS CUI 2011AA)
58776007 (SNOMED CT 2011_0131)
C1831743 (UMLS CUI 2011AA)
Manifest secondary malignancy or other form of cancer in the previous 5 years (excluding basalioma, in situ cervical cancer, incidental prostatic cancer)
Item
Manifest secondary malignancy or other form of cancer in the previous 5 years (excluding basalioma, in situ cervical cancer, incidental prostatic cancer)
boolean
C0205319 (UMLS CUI 2011AA)
250255003 (SNOMED CT 2011_0131)
C0751623 (UMLS CUI 2011AA)
10039801 (MedDRA 14.1)
C0205394 (UMLS CUI 2011AA)
74964007 (SNOMED CT 2011_0131)
C0006826 (UMLS CUI 2011AA)
363346000 (SNOMED CT 2011_0131)
10028997 (MedDRA 14.1)
MTHU010328 (LOINC Version 232)
C00-C96 (ICD-10-CM Version 2010)
CL411789 (UMLS CUI 2011AA)
C0007117 (UMLS CUI 2011AA)
1338007, 254701007 (SNOMED CT 2011_0131)
10004146 (MedDRA 14.1)
C0851140 (UMLS CUI 2011AA)
92564006 (SNOMED CT 2011_0131)
10061809 (MedDRA 14.1)
D06.9 (ICD-10-CM Version 2010)
233.1 (ICD-9-CM Version 2011)
C0444507 (UMLS CUI 2011AA)
261087003 (SNOMED CT 2011_0131)
C0600139 (UMLS CUI 2011AA)
254900004 (SNOMED CT 2011_0131)
10036921 (MedDRA 14.1)
Subject pregnant or breast feeding, or planning to become pregnant within 6 months after the end of treatment
Item
Subject pregnant or breast feeding, or planning to become pregnant within 6 months after the end of treatment
boolean
C0549206 (UMLS CUI 2011AA)
10036586 (MedDRA 14.1)
C0006147 (UMLS CUI 2011AA)
10006247 (MedDRA 14.1)
C0032992 (UMLS CUI 2011AA)
169565003 (SNOMED CT 2011_0131)
Subject (male or female) is not willing to use highly effective methods of contraception (per institutional standard) during treatment and for 3 months (male or female) after the end of treatment (adequate: oral contraceptives, intrauterine device or barrier method in conjunction with spermicidal jelly).
Item
Subject (male or female) is not willing to use highly effective methods of contraception (per institutional standard) during treatment and for 3 months (male or female) after the end of treatment (adequate: oral contraceptives, intrauterine device or barrier method in conjunction with spermicidal jelly).
boolean
C0024554 (UMLS CUI 2011AA)
248153007 (SNOMED CT 2011_0131)
M (HL7 V3 2006_05)
C0015780 (UMLS CUI 2011AA)
248152002 (SNOMED CT 2011_0131)
F (HL7 V3 2006_05)
C0558080 (UMLS CUI 2011AA)
225465005 (SNOMED CT 2011_0131)
C0700589 (UMLS CUI 2011AA)
146680009 (SNOMED CT 2011_0131)
10010808 (MedDRA 14.1)
C0009905 (UMLS CUI 2011AA)
59261009 (SNOMED CT 2011_0131)
C0021900 (UMLS CUI 2011AA)
268460000 (SNOMED CT 2011_0131)
10022745 (MedDRA 14.1)
C0004764 (UMLS CUI 2011AA)
225370004 (SNOMED CT 2011_0131)
C2699427 (UMLS CUI 2011AA)
C2985330 (UMLS CUI 2011AA)
Active participation in other clinical studies in the previous 4 weeks
Item
Active participation in other clinical studies in the previous 4 weeks
boolean
C0679823 (UMLS CUI 2011AA)
PART (HL7 V3 2006_05)
C0205394 (UMLS CUI 2011AA)
74964007 (SNOMED CT 2011_0131)
C0008976 (UMLS CUI 2011AA)
110465008 (SNOMED CT 2011_0131)
Prior systemic therapy with cytostatics or immunotherapeutic agents
Item
Prior systemic therapy with cytostatics or immunotherapeutic agents
boolean
C0332152 (UMLS CUI 2011AA)
288556008 (SNOMED CT 2011_0131)
C1515119 (UMLS CUI 2011AA)
C0010858 (UMLS CUI 2011AA)
373221003 (SNOMED CT 2011_0131)
C0876248 (UMLS CUI 2011AA)
255683006 (SNOMED CT 2011_0131)
Concurrent use of other anticancer treatments after study commencement
Item
Concurrent use of other anticancer treatments after study commencement
boolean
C0205420 (UMLS CUI 2011AA)
68405009 (SNOMED CT 2011_0131)
C1524063 (UMLS CUI 2011AA)
260676000 (SNOMED CT 2011_0131)
C0205394 (UMLS CUI 2011AA)
74964007 (SNOMED CT 2011_0131)
C0920425 (UMLS CUI 2011AA)
Intravesical chemotherapy in the previous 4 weeks
Item
intravesical chemotherapy
boolean
CL388462 (UMLS CUI 2011AA)
Radiotherapy in the previous 4 weeks
Item
radiation therapy, RT
boolean
C0034619 (UMLS CUI 2011AA)
Previous radiotherapy in which all lesions to be used for the evaluation of tumour response were irradiated
Item
Previous radiotherapy in which all lesions to be used for the evaluation of tumour response were irradiated
boolean
CL414551 (UMLS CUI 2011AA)
C0221198 (UMLS CUI 2011AA)
49755003 (SNOMED CT 2011_0131)
C0220825 (UMLS CUI 2011AA)
C0006826 (UMLS CUI 2011AA)
363346000 (SNOMED CT 2011_0131)
10028997 (MedDRA 14.1)
MTHU010328 (LOINC Version 232)
C00-C96 (ICD-10-CM Version 2010)
C0871261 (UMLS CUI 2011AA)
Patients in a closed institution according to an authority or court decision
Item
Patients in a closed institution according to an authority or court decision
boolean
C0030705 (UMLS CUI 2011AA)
116154003 (SNOMED CT 2011_0131)
C0587267 (UMLS CUI 2011AA)
29179001 (SNOMED CT 2011_0131)
C0021622 (UMLS CUI 2011AA)
C0332290 (UMLS CUI 2011AA)
385433004 (SNOMED CT 2011_0131)
C0599437 (UMLS CUI 2011AA)
C0242364 (UMLS CUI 2011AA)